SubHero Banner
Text

November 2023

Core topics in this month’s edition include:

  • Adzynma (ADAMTS13, recombinant-krhn) – new orphan drug approval
  • Wegovy (semaglutide) – drug update
  • Zepbound (tirzepatide) – new drug approval

Download PDF

Text